Navigation Links
New Book Chapter from CEM on Microwave Peptide Synthesis
Date:6/11/2013

MATTHEWS, N.C., June 11, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce its contribution of a new chapter on microwave peptide synthesis, which appears in Microwaves in Organic Synthesis, Volume 2, Third Edition, edited by Professor Antonio de la Hoz and Dr. Andre Loupy.

(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

The chapter entitled, "Microwave-Enhanced Synthesis of Peptides, Proteins and Peptidomimetics," was authored by Jonathan M. Collins, the initial developer of CEM's microwave peptide synthesis technology, and offers an in-depth discussion of the theory, technology, and chemistry behind incorporating microwave energy into peptide synthesis with more than 300 cited references.  It provides a complete overview and analysis of all research to date in this field along with a mechanistic discussion of the common chemistries and side reactions encountered in solid phase peptide synthesis. 

"This chapter is intended to be a useful tool for any researcher using or considering using microwave irradiation for solid phase synthesis of peptides and peptidomimetics," said Jonathan M. Collins, "the field is rapidly evolving and microwave has proven useful for reducing synthesis times as well as in many cases increasing peptide product purity."

Collins, who holds degrees from the University of Florida, Northwestern University, and Stanford University, initiated CEM's movement into microwave peptide synthesis in late 2002. Currently, Director of Business Development for CEM Corporation, Collins continues to research microwave peptide synthesis and develop new methods and technologies to improve the process. In 2013, CEM plans to announce several major developments in microwave peptide synthesis that will continue its leadership position in this field.

Microwaves in Organic Synthesis, Volume 2, Third Edition is currently available from Wiley-Blackwell (DOI: 10.1002/9783527651313.ch20).

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom& Ireland, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. All Market Research New Report @ The Worldwide Industry & Regional Market Opportunities With Forecasts to 2016 for Amplifiers and Integrated Microwave Assemblies. (Code name: AIMAs)
2. UCLA-led research team develops worlds most powerful nanoscale microwave oscillators
3. Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrows air conditioners
4. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
5. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
6. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
7. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
8. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
9. Small peptide ameliorates autoimmune skin blistering disease in mice
10. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
11. Strategic Analysis of the Collagen Peptide Market in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
(Date:3/22/2017)... -- Good Start Genetics, a leading family genomics company, ... covered lives mark through its most recent payor addition, ... . With newly signed contracts nationally and others in ... acceptance based on the quality of its science, the ... industry-leading customer care and support and its published cost-effectiveness ...
(Date:3/22/2017)... March 22, 2017   iSpecimen ®, the ... Doctors Pathology Service (DPS), a full-service anatomic ... the United States , has joined a ... Information Network (DHIN) to make human biospecimens and ... The novel program, announced in 2015 as a collaboration ...
Breaking Biology Technology:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/9/2017)... The biomass boiler market report by Transparency Market Research ... in terms of revenue (US$ Mn) based on the ... boilers has been segmented on the basis of feedstock ... based on feedstock type, has been segmented into woody ... urban residues, and others. On the basis of product ...
Breaking Biology News(10 mins):